Asthma and Allergic Diseases Cooperative Research Centers

The summary for the Asthma and Allergic Diseases Cooperative Research Centers Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Asthma and Allergic Diseases Cooperative Research Centers
	CFDA Number:	93.855
	CFDA Description:	Allergy, Immunology and Transplantation Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-AI-05-027
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	May 25, 2005
	Creation Date:	May 25, 2005
	Original Closing Date for Applications:	Oct 12, 2005
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Nov 11, 2005
	Expected Number of Awards:	7
	Estimated Total Program Funding:	$11,000,000
	Federal Grant Award Ceiling:	$1,000,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Small businesses Public and State controlled institutions of higher education Private institutions of higher education State governments County governments City or township governments Special district governments Independent school districts Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities
Additional Information on Eligibility: Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are not eligible to apply as the primary applicant but may enter into a consortium with the domestic institution as the primary applicant.
Grant Description: - The National Institute of Allergy and Infectious Diseases (NIAID) invites applications from single institutions and consortia of institutions to participate in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program. The purpose of this RFA is to support basic and clinical research on the immunological basis, pathobiology, diagnosis, treatment and prevention of asthma and allergic diseases and to accelerate the application of fundamental knowledge of immune function to the investigation, prevention, and treatment of asthma and allergic diseases. - In FY 2006, NIAID anticipates awarding a total of $11 million to support the Centers. Additional discretionary funds of $1 million per year will be provided to support new projects on emerging opportunities. - Seven to ten new awards are anticipated. - This initiative will be funded using the multi-project Cooperative Agreement (U19) award mechanism. - A minimum of two research projects must be proposed. At least one of the projects must focus on immunologic aspects of asthma and/or allergic diseases in humans, and must be qualified as clinical research as defined in NIH grant guidance and policy (http://grants.nih.gov/grants/policy/hs/index.htm). - An institution may submit only one application; however, applications may include investigators from more than one institution if such arrangements enhance the scientific strength of the proposed research program. In addition, a Principal Investigator may serve as a Project Leader in a multi-project application if there is no scientific overlap with the application submitted by the Principal Investigator. - Eligible organizations include: domestic for-profit and non-profit organizations; public and private institutions, such as universities, colleges, hospitals, laboratories, units of State and local governments, and eligible agencies of the Federal government. Foreign institutions are not eligible to apply as the primary applicant but may enter into a consortium with a domestic institution serving as the primary applicant. - Eligible Principal Investigators include all individuals with the skills, knowledge, and resources necessary to carry out the proposed research. Racial/ethnic minority individuals, women, and persons with disabilities are encouraged to apply as Principal Investigators. - The PHS 398 document is available at http://grants.nih.gov/grants/funding/phs398/phs398.html. For further assistance contact Grantsinfo, Telephone (301)435-0714, Email: Grantsinfo@nih.gov. - Telecommunications for the hearing impaired is available at: TTY 301-451-0088.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-05-027.html http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-05-027.html
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
Similar Government Grants: • Innovation for HIV Vaccine Discovery (R01); • NIAID Clinical Trial Implementation Cooperative Agreement (U01); • Therapeutics for Neurotropic Biodefense Toxins and Pathogens (R21/R33); • Strategies for the Protection of Pregnant Women and Infants Against Infectious Diseases (R01); • Predictive Biodosimetry: Discovery and Development of Biomarkers for Acute and Delayed Radiation Inj...; • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Radionuclide Decorporation Agents for Radiation/Nuclear Emergencies: Project BioShield (R01); • Asthma and Allergic Diseases Cooperative Research Centers (U19); • Medical Countermeasures to Restore Gastrointestinal Function after Radiation Exposure: Project Biosh...